04/16/09 - USPTO Class 514 |
8 views | #20090099162 | Prev - Next | About this Page  
Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai, Hetero Ring Is Six-membered And Includes At Least Nitrogen And Oxygen As Ring Hetero Atoms (e.g., Monocyclic 1,2- And 1,3-oxazines, Etc.), Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos (e.g., Maytansinoids, Etc.), Bicyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos (e.g., 1,4-benzoxazines, Etc.)Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias description/claims
The Patent Description & Claims data below is from USPTO Patent Application 20090099162, Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias.
Brief Patent Description - Full Patent Description - Patent Application Claims
data error
132
NoSuchKeyThe specified key does not exist.live/I20090416-xml/US20090099162A1-20090416.XMLD5264A4F183950A5HIFWblfTNsTxKLexfD0CkIYFmKAIKJGNwy3Xux0gyiMyv11vAAxdvG/3rBQ2W6Ry
0
|
